CareDx, Inc (CDNA)

NASDAQ: CDNA · IEX Real-Time Price · USD
12.01
+1.37 (12.88%)
At close: Mar 1, 2024, 4:00 PM
11.81
-0.20 (-1.67%)
After-hours: Mar 1, 2024, 7:59 PM EST

Company Description

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers.

It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients.

The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software.

In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients.

The company offers its products directly to customers, as well as through third-party distributors and sub-distributors.

It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss.

The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

CareDx, Inc
CareDx logo
Country United States
IPO Date Jul 17, 2014
Industry Diagnostics & Research
Sector Healthcare
Employees 727
CEO Abhishek Jain

Contact Details

Address:
8000 Marina Blvd, 4th Floor
Brisbane, California 94005
United States
Phone 415-287-2300
Website caredx.com

Stock Details

Ticker Symbol CDNA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001217234
CUSIP Number 14167L103
ISIN Number US14167L1035
Employer ID 94-3316839
SIC Code 8071

Key Executives

Name Position
Abhishek Jain Chief Financial Officer and Principal Accounting Officer
Dr. Peter Maag Ph.D. Executive Director
Alexander L. Johnson President of Patient and Testing Services
Marica Grskovic Ph.D. Chief Operating Officer
Dr. Robert N. Woodward Ph.D. Chief Scientific Officer
GS Jha Senior Vice President, Chief Information Officer and Chief Information Security Officer
Ian Cooney Vice President of Investor Relations
Jeffrey A. Novack General Counsel
Stacey Follon Senior Vice President and Head of Human Resources
Kashif Rathore Chief of Patient and Digital Solutions

Latest SEC Filings

Date Type Title
Mar 1, 2024 POS AM Post-Effective amendments for registration statement
Feb 28, 2024 10-K Annual Report
Feb 28, 2024 8-K Current Report
Feb 28, 2024 POSASR Filing
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Feb 5, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals